E Douglas Kramer
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac, Anesthesia and Surgical Outcomes
- Oncology top 10%
- Cancer Treatment and Pharmacology
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Cardiac, Anesthesia and Surgical Outcomes 2
- Oncology 5
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 1
- Co-authors
- Joseph J. Sanger (5 shared papers)James L. Speyer (3 shared papers)Mariano Rey (3 shared papers)Anne Zeleniuch‐Jacquotte (3 shared papers)J Wernz (2 shared papers)Marleen Meyers (2 shared papers)Howard S. Höchster (2 shared papers)V J Ferrans (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Treatment Reviews (1 paper)Journal of Vascular Surgery (1 paper)New England Journal of Medicine (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesHondurasArgentina
In The Last Decade
E Douglas Kramer
7 papers receiving 749 citations
Peers
Comparison fields: 5 of 65
- Cardiology and Cardiovascular Medicine 632
- Oncology 346
- Biophysics 54
- Pulmonary and Respiratory Medicine 260
- Dermatology 58
Countries citing papers authored by E Douglas Kramer
This map shows the geographic impact of E Douglas Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Douglas Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Douglas Kramer more than expected).
Fields of papers citing papers by E Douglas Kramer
This network shows the impact of papers produced by E Douglas Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Douglas Kramer. The network helps show where E Douglas Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside E Douglas Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 281 | |
| 2 | 1992 | 263 | |
| 3 | 1984 | 109 | |
| 4 | The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures. | 1985 | 98 |
| 5 | 1990 | 20 | |
| 6 | 2022 | 12 | |
| 7 | 2020 | 8 |
About E Douglas Kramer
E Douglas Kramer is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Surgery, Pulmonary and Respiratory Medicine and Dermatology, having authored 7 papers that have together received 791 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), HER2/EGFR in Cancer Research (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Electron Spin Resonance Studies (1 paper), Management of metastatic bone disease (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (632 citations), Oncology (346 citations), Biophysics (54 citations), Pulmonary and Respiratory Medicine (260 citations) and Dermatology (58 citations). E Douglas Kramer has collaborated with scholars based in United States, Honduras and Argentina. Frequent co-authors include Joseph J. Sanger, James L. Speyer, Mariano Rey, Anne Zeleniuch‐Jacquotte, J Wernz, Marleen Meyers, Howard S. Höchster, V J Ferrans, Franco M. Muggia and Ronald H. Blum. Their work appears in journals such as Journal of Clinical Oncology, Cancer Treatment Reviews, Journal of Vascular Surgery, New England Journal of Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.